Herein, we hypothesize that a combined questionnaire–serology screening protocol, including HGB, carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9) testing, could facilitate and optimize gastric cancer screening workflows. The gene discussed is CEACAM5; the disease is gastric cancer.